Speaking of Medicine – Mid-Year OPDP Enforcement Review
Eye on FDA
AUGUST 2, 2022
By 2002, the number had dropped to 28, reviving somewhat by the end of that decade when it reached 52 in 2010. The characterization of investigative data resulted in a violation related to promotion of an unapproved compound. But when it comes to enforcement things have changed greatly over the years.
Let's personalize your content